Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 4, 2005, Pages 257-266

  Paulose Ram, Ryne ^a   Hirsch, Rosemarie ^a   Dillon, Charles ^a   Gu, Qiuping ^a  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

Acetaminophen; Analgesics; Aspirin; Drug utilization; NHANES; NSAIDSs; Prevalence; Survey

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ASCRIPTIN; CINNAMEDRINE; COMTREX; CORTICOSTEROID; DICLOFENAC; EXCEDRIN; IBUPROFEN; INDOMETACIN; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PABRIN; PARACETAMOL; PARACETAMOL DERIVATIVE; PARACETAMOL PLUS SALICYLIC ACID; PIROXICAM; SULINDAC; TICLOPIDINE; TOLMETIN; UNCLASSIFIED DRUG; VANQUISH; WARFARIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; DIGESTIVE SYSTEM PERFORATION; DRUG UTILIZATION; DUODENUM ULCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEADACHE; HEALTH INSURANCE; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEPHROTOXICITY; PATIENT MONITORING; PEPTIC ULCER; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STOMACH ULCER; TREATMENT INDICATION; UNITED STATES;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG UTILIZATION; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; UNITED STATES;

EID: 17244374157     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.983     Document Type: Article

References (35)

1. Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1997; 96: 2751-2753.
2. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 2002; 136(2): 157-160.
3. Hernandez-Diaz S, Garcia Rodriguez LA. Association between nonsteriodal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-2099.
4. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
5. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994; 154: 42-46.
6. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-1416.
7. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. New Engl J Med 1994; 331(25): 1675-1679.
8. Segasothy M, Samad SA, Sulfigar JM, Bennett WM. Chronic renal disease and papillary necrosis associated with long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994; 24: 17-24.
9. Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, Duque Oliart A, Ris Romeu J. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996; 156: 2433-2439.
10. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. J Am Med Assoc 1994; 272: 1945-1850.
11. Lee WM. Drug induced hepatoxicity. New Engl J Med 1995; 333: 1116-1127.
12. Schiøodt FV, Rochling FA, Casey DL, Lee WM. Acetammophen toxicity in an urban county hospital. New Engl J Med 1997; 337 1112-1117.
13. Jonhson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289-300.
14. Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med 2002; 162(19): 2204-2208.
15. Matzke GR. Nonrenal toxcities of acetaminophen, aspirin, and nonsteriodal anti-inflammatory agents. Am J Kidney Dis 1996; 28 S63-S70.
16. Reisine T, Pasternak G. Opiod analgesics and antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE (eds). McGraw-Hill: New York; 1996; 521-555.
17. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE (eds). McGraw-Hill: New York; 1996; 617-657.
18. Aronson MD. Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther 1997; 19: 422-432.
19. Food and Drug Administration. Labeling revisions for NSAIDs. FDA Drug Bull 1989; 19(1): 3-4.
20. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult populations: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Safe 2003; 12(4): 315-326.
21. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, non-steroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Safe 2002; 11: 687-693.
22. National Center for Health Statistics. NHANES 1999-2000 Addendum to the NHANES III Analytic Guideline. Available at: http://www.cdc.gov/nchs/data/nhanes/guidelines1.pdf [Accessed 17 April 2003].
23. National Center for Health Statistics. NHANES analgesic pain reliever questionnaire files. Available at: http://www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.htm [Accessed 17 April 2003].
24. SAS Institute Inc. SAS Procedure Guide, Version 6, 3rd edn. Cary, NC; 1990.
25. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Institute: Research Triangle Park, NC; 1996.
26. Pleis JR, Coles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1999. National Center for Health Statistics. Vital Health Stat 2003; 10(212): 4-5.
27. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85-88.
28. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114 4): 257-663.
29. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for severe gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787-796.
30. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anti-coagulants places elderly persons at a higher risk hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 1665-1670.
31. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-740.
32. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and the risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999; 116: 1305-1309.
33. The Food and Drug Administration. Over-the-counter human drugs; labeling requirements. Available at: http://www.fda.gov/cder/otc/label/label-fr-reg.htm [Accessed 11 August 2003].
34. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41(7): 646-657.
35. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58(6): 885-894.